Actively Recruiting

Phase Not Applicable
Age: 18Years - 60Years
All Genders
Healthy Volunteers
NCT07220265

Impact of Phenylalanine Elevations on Brain and Cognition in Adult PKU Carriers

Led by University of Missouri-Columbia · Updated on 2026-03-11

36

Participants Needed

1

Research Sites

53 weeks

Total Duration

On this page

Sponsors

U

University of Missouri-Columbia

Lead Sponsor

E

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

Collaborating Sponsor

AI-Summary

What this Trial Is About

The goal of this clinical trial is to advance our understanding of the cognitive and neurophysiologic sequelae associated with suboptimal phenylalanine (Phe) metabolism in heterozygous carriers of phenylketonuria (PKU). The main questions it aims to answer are: * Do PKU carriers experience prolonged elevations in brain Phe levels following oral ingestion of dietary Phe? * Do PKU carriers experience disruptions in cognitive functioning following oral ingestion of dietary Phe? * Do PKU carriers experience atypical brain activity following oral ingestion of dietary Phe? Researchers will compare PKU carriers and non-carriers following oral ingestion of dietary Phe and a placebo. Participants will: * Consume Phe or a placebo at two separate visits to our facility * At each visit, they will complete a series of MRIs and cognitive tests throughout the day

CONDITIONS

Official Title

Impact of Phenylalanine Elevations on Brain and Cognition in Adult PKU Carriers

Who Can Participate

Age: 18Years - 60Years
All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Age 18-60 years
  • For the PKU carrier group: Parent of an individual with PKU or confirmed PKU carrier (e.g., sibling with genetic testing)
  • For the non-carrier group: No PKU and no family history of PKU
Not Eligible

You will not qualify if you...

  • Obesity with body mass index (BMI) over 30
  • Taking oral contraceptives on the day of testing
  • Positive cotinine urine test indicating nicotine use
  • History of major neurological conditions affecting brain health (e.g., multiple sclerosis, severe head injury, Parkinson's disease)
  • Contraindications for MRI including pregnancy, plans for pregnancy, or metal objects inside the body (e.g., surgical staples, middle ear prosthesis, metal in eye, pacemaker)

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

University of Missouri-Columbia

Columbia, Missouri, United States, 65201

Actively Recruiting

Loading map...

Research Team

S

Shawn Christ

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

DOUBLE

Allocation

RANDOMIZED

Model

CROSSOVER

Primary Purpose

BASIC_SCIENCE

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Impact of Phenylalanine Elevations on Brain and Cognition in Adult PKU Carriers | DecenTrialz